Sign in / Join Now
ETFs & Funds
FDA approves new use for Eylea. More upside to Regeneron $
Add a reply...
Latest StockTalks »
people get REGN breaking news and analysis by email alert.
Get email alerts on REGN »
Regeneron Pharmaceuticals, Inc.
Get latest price
From other sites
Regeneron Drug Fails in Combination Trial (REGN)
at Investopedia (Oct 3, 2016)
The New #33 Most Shorted Nasdaq 100 Component: Regeneron Pharmaceuticals
at TheStreet (Sep 27, 2016)
Zacks.com featured highlights: Regeneron Pharmaceuticals, Nordstrom, Intel, Nu Skin Enterprises and Priceline GroupZacks.com featured highlights: Regeneron Pharmaceuticals, Nordstrom, Intel, Nu Skin Enterprises and Priceline Group
at Zacks.com (Sep 27, 2016)
Regeneron Win Review for Dermatitis Drug (REGN)
at Investopedia (Sep 26, 2016)
Regeneron Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for REGN
at Nasdaq.com (Sep 23, 2016)